Dentifying predictive factors in melanoma progression

Oncology Reports

Volumn 5, Issue 3, 1998, Pages 569-575

  Dabrowska, Dorota M ^a   Elashoff, R M ^a   Ho, W ^a   Morton, D L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

Melanoma progression; Predictive factors

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER STAGING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STATISTICAL ANALYSIS; TUMOR LOCALIZATION;

ADULT; AGE FACTORS; COHORT STUDIES; DATABASES, FACTUAL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MARKOV CHAINS; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX CHARACTERISTICS; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0031969822     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Morton DL, Essner R, Kirkwood JM and Parker RG: Malignant melanoma. In: Cancer Medicinea. Holland JF, Frei E, Bast R, Kuffe D, Morton DL and Weichselbaum R (eds). 4th edition. Williams & Wilkins, Baltimore, pp2467-2502, 1997.
2. Balch CM, Murad TM, Soong SJ, Ingalls AL, Halpern, NB and Maddox WA: A multifactorial analysis of melanoma. Prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg 188: 732-742, 1978.
3. Drzewiecki KT and Andersen PK: Survival with malignant melanoma. A regression analysis of prognostic factors. Cancer 49: 2414-2419, 1982.
4. Schomeckel C, Bockelbrink A, Bockelbrink H, Koutsis J and Braun-Falco O: Low- and high-risk malignant melanoma: I. Evaluation of clinical and histopathological prognosticators in 585 cases. Eur J Cancer Clin Oncol 19: 227-235, 1983.
5. Balch CM, Soong SJ, Shaw HM, Ulrist MM and McCarthy WH: An analysis of prognostic factors in 8,500 patients with cutaneous melanoma. In: Cutaneous Melanoma. 2nd edition. Lippincott, Philadelphia, PA, pp165-187, 1992.
6. Wanek LA, Elashoff RM, Goradia T, Morton DL and Cochran AJ: Application of multistage Markov modeling to malignant melanoma progression. Cancer 72: 336-343, 1994.
7. Eldh J, Boyerd B and Peterson LE: Prognostic factors in cutaneous malignant newline melanoma in stage I. A clinical, morphological and multivariate analysis. Scand J Plast Reconstr Surg 12: 243-250, 1978.
8. Clark WH, Elder DE, Guerry D IV, Braitman LE, Track BJ, Schultz D, Synnestvedt M and Halpern AC: Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 81: 1893-1904, 1989.
9. Day CL, Sober AJ, Kopf AW, Lew RA, Mihm MC. Colomb FM, et al: A prognostic model for clinical stage I melanoma of the lower extremity: location on foot as independent risk factor for recurrent disease. Surgery 89. 599-603, 1981.
10. Day CL, Sober AJ, Kopf AW, Lew RA, Mihm MC, Hennessey P, el al: A prognostic model for clinical stage I melanoma of the upper extremity: the importance of anatomic subsites in predicting recurrent disease. Ann Sura 193: 436-440, 1981.
11. Balch CM, Soong SJ, Milton GW, Shaw HM, McGovern VJ Murad TM, et al: A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA and new South Wales, Australia. Ann Surg 196: 677-684, 1982.
12. Balch CM, Soong SJ, Murad TM, Ingalls AL and Maddox WA: A multifactorial analysis of melanoma: 11. Prognostic factors in patients with stage I (localized) melanoma. Surgery 86: 343, 1979.
13. Vollmer R: Maliganant melanoma. A multivariate analysis of prognostic factors. Pathol Annu 24: 383-407, 1989.
14. Buttner P, Garbe C, Bertz J, et al: Primary cutaneous melanoma. Optimized cut-off points of tumor thickness and importance of Clark's level for prognostic classification. Cancer 75: 2499-2506, 1995.
15. Buzaid AC, Merrick, IR, Balch CM, Soong SJ, et al: Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol 15: 1039-1051, 1997.
16. Morton DL, Davtyan D, Wanek L, et al: Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness. Cancer 75: 3737-3743, 1995.
17. Balch C: Cutaneous melanoma: prognosis and treatment results worldwide. Semin Surg Oncol 8: 400-414, 1992.
18. Day CL, Mihm MC, Lew RA, Harris MN, Kopf AW, Fitzpatrick TB, et al: Newline prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51-3.99 mm): a conceptual model for tumor growth and metastasis. Ann Surg 195: 35-43, 1982.
19. Schomeckel C, Bockelbrink A, Bockelbrink H and Braun-Falco O: Low- and high-risk malignant melanoma: II. Multivariate analyses for prognostic classification. Eur J Cancer Clin Oncol 19: 237-243, 1983.
20. Aalen OO and Johansen S: An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scand J Statist 5: 141-150, 1978.
21. Andersen PK, Borgan O, Gill RD and Keiding N: Statistical models based on counting processes. Springer Verlag, 1993.